HUNT FOR BIOMARKER OF CARCINOMA BREAST: ANTINUCLEAR ANTIBODIES

Authors

  • Dr. S. Gowri, Dr. M. Govindan, Dr. T.G. Aruljothi, Dr. S. Poongodi @ Lakshmi Author

DOI:

https://doi.org/10.48047/

Keywords:

.

Abstract

Background: Carcinoma breast is the second most common malignancy among women which evolves silently and ends in devastation. Tumor cell death induces antinuclear antibody (ANA) production that can be measured by enzyme linked immunosorbent assay (ELISA). Hence this study was undertaken to determine the utility of ANA ELISA in early diagnosis of carcinoma breast.

Downloads

Download data is not yet available.

Published

2024-09-11

Issue

Vol. 15 No. 9 (2024): volume 15 issue 9 (2024)

Section

Articles